Significant improvements in six-minute walking distance were reported in the STELLAR Phase III Trial whose findings were unveiled during a Featured Clinical Research session on the final day of the March 4-6 American College of Cardiology Scientific Session, ACC23 Together with WCC. Researchers added a novel first-in-class medication in combination with background therapy in patients with pulmonary arterial hypertension (PAH), a severe, progressive condition that affects the heart and lungs.
Indian benchmark indices began their day in green, but at closing ended up losing 0.5%. Nifty 50 closed above 18100, while BSE Sensex down 241.02 points.
MIL-OSI USA: Novel blood test helps evaluate severity in pulmonary arterial hypertension, a rare lung disease foreignaffairs.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from foreignaffairs.co.nz Daily Mail and Mail on Sunday newspapers.
Novel blood test helps evaluate severity in pulmonary arterial hypertension, rare lung disease miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.